These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33355233)

  • 1. S100B protein level for the detection of clinically significant intracranial haemorrhage in patients with mild traumatic brain injury: a subanalysis of a prospective cohort study.
    Blais Lécuyer J; Mercier É; Tardif PA; Archambault PM; Chauny JM; Berthelot S; Frenette J; Perry J; Stiell I; Émond M; Lee J; Lang E; McRae A; Boucher V; Le Sage N
    Emerg Med J; 2021 Apr; 38(4):285-289. PubMed ID: 33355233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of S100B in detecting intracranial injury in elderly patients with mild traumatic brain injury.
    Santing JAL; Hopman JH; Verheul RJ; van der Naalt J; van den Brand CL; Jellema K
    Injury; 2024 Mar; 55(3):111313. PubMed ID: 38219558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of S100B level in detecting mild traumatic brain injury in intoxicated patients.
    Rahimian S; Potteiger S; Loynd R; Mercogliano C; Sigal A; Short A; Donato A
    Am J Emerg Med; 2020 Apr; 38(4):799-805. PubMed ID: 31884023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
    Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
    Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B serum protein cannot predict secondary intracranial haemorrhage after mild head injury in patients with low-dose acetylsalicylic acid prophylaxis.
    Ernstbrunner L; Korn G; Ernstbrunner E; Auffarth A; Tauber M; Resch H; Moroder P
    Brain Inj; 2016; 30(1):43-7. PubMed ID: 26580090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study - "the PreTBI I study".
    Seidenfaden SC; Kjerulff JL; Juul N; Kirkegaard H; Møller MF; Münster AB; Bøtker MT
    Scand J Trauma Resusc Emerg Med; 2021 Jun; 29(1):75. PubMed ID: 34078435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of S100B use in a cohort of Spanish patients with mild traumatic brain injury: a multicentre study.
    Egea-Guerrero JJ; Rodríguez-Rodríguez A; Quintana-Díaz M; Freire-Aragón MD; Raya-Collados D; Hernández-García C; Ortiz-Manzano Á; Vilches-Arenas Á; Díez-Naz A; Guerrero JM; Murillo-Cabezas F
    Brain Inj; 2018; 32(4):459-463. PubMed ID: 29355397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker S100B in plasma a screening tool for mild traumatic brain injury in an emergency department.
    H Hopman J; A L Santing J; A Foks K; J Verheul R; M van der Linden C; L van den Brand C; Jellema K
    Brain Inj; 2023 Jan; 37(1):47-53. PubMed ID: 36397287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan.
    Bazarian JJ; Blyth BJ; He H; Mookerjee S; Jones C; Kiechle K; Moynihan R; Wojcik SM; Grant WD; Secreti LM; Triner W; Moscati R; Leinhart A; Ellis GL; Khan J
    J Neurotrauma; 2013 Oct; 30(20):1747-54. PubMed ID: 23758329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels.
    Asadollahi S; Heidari K; Taghizadeh M; Seidabadi AM; Jamshidian M; Vafaee A; Manoochehri M; Shojaee AH; Hatamabadi HR
    Brain Inj; 2016; 30(2):172-8. PubMed ID: 26671496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma.
    Manzano S; Holzinger IB; Kellenberger CJ; Lacroix L; Klima-Lange D; Hersberger M; La Scala G; Altermatt S; Staubli G
    Emerg Med J; 2016 Jan; 33(1):42-6. PubMed ID: 26283067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Biomarker S100B and Mild Traumatic Brain Injury: A Meta-analysis.
    Oris C; Pereira B; Durif J; Simon-Pimmel J; Castellani C; Manzano S; Sapin V; Bouvier D
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29716980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of S100B as a rule-out test for intracranial pathology in head-injured patients presenting to the emergency department who meet NICE Head Injury Guideline criteria for CT-head scan.
    Rogan A; Sik A; Dickinson E; Patel V; Peckler B; McQuade D; Larsen PD;
    Emerg Med J; 2023 Mar; 40(3):159-166. PubMed ID: 36323496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults.
    Minkkinen M; Iverson GL; Kotilainen AK; Pauniaho SL; Mattila VM; Lehtimäki T; Berghem K; Posti JP; Luoto TM
    J Neurotrauma; 2019 Oct; 36(20):2904-2912. PubMed ID: 31111795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of S100B in the diagnosis of suspected intracranial hemorrhage after minor head injury in patients who are receiving platelet aggregation inhibitors and in patients 65 years of age and older.
    Thaler HW; Schmidsfeld J; Pusch M; Pienaar S; Wunderer J; Pittermann P; Valenta R; Gleiss A; Fialka C; Mousavi M
    J Neurosurg; 2015 Nov; 123(5):1202-8. PubMed ID: 26148794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury.
    Lagerstedt L; Egea-Guerrero JJ; Bustamante A; Montaner J; Rodríguez-Rodríguez A; El Rahal A; Turck N; Quintana M; García-Armengol R; Prica CM; Andereggen E; Rinaldi L; Sarrafzadeh A; Schaller K; Sanchez JC
    PLoS One; 2017; 12(4):e0175572. PubMed ID: 28419114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Performance of Blood S100B in the Management of Patients Over 65 Years Old With Mild Traumatic Brain Injury.
    Oris C; Bouillon-Minois JB; Pinguet J; Kahouadji S; Durif J; Meslé V; Pereira B; Schmidt J; Sapin V; Bouvier D
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):1471-1479. PubMed ID: 33647933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100B outperforms clinical decision rules for the identification of intracranial injury on head CT scan after mild traumatic brain injury.
    Jones CMC; Harmon C; McCann M; Gunyan H; Bazarian JJ
    Brain Inj; 2020 Feb; 34(3):407-414. PubMed ID: 32064945
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography.
    Heidari K; Asadollahi S; Jamshidian M; Abrishamchi SN; Nouroozi M
    Brain Inj; 2015; 29(1):33-40. PubMed ID: 25207823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.